Prof. Elfriede Leniger-Follert was the head of a research group at the Max Planck Institute at the Institute of Systems Physiology that focussed on the oxygen supply to the brain.
Her discovery at the time was that magnesium could help to widen constricted microvessels again
and normalise the oxygen supply. She discovered this mechanism of the disease-related narrowing of the microvessels in 1983. This reduces
the oxygen supply to the brain, the retina, the inner ear, the lungs and liver, the kidneys and the feet.
In all circulatory disorders, the outer side of the vascular muscle cells is negatively charged compared to the positively charged inner side
(potassium depolarisation). This reversal is the trigger for the shortening of the ring-shaped vascular muscles, which thus become narrower.
A few years later, she discovered that magnesium ions are capable of reversing the unfavourable charge distribution. This
opens and widens the blood vessels again.
Prof. Leniger-Follert uses direct IV injections into the veins and oxygen concentrators directly after.
We have developed a similar therapy based on the decade long knowledge of our medical team and have adapted her findings to the use with Hyperbaric Oxygen combined with IV treatment with Magnesium NaCl solution.
Magnesium Oxygen Therapy - but literally supercharged.